Enhanced immune recognition of cryptic glycan markers in human tumors. - Wikidata - awgldk - TriplyDB

Enhanced immune recognition of cryptic glycan markers in human tumors.

Enhanced immune recognition of cryptic glycan markers in human tumors.

http://www.wikidata.org/entity/Q37133417

about

Protein modifications as potential biomarkers in breast cancer.Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin.Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.Glyco-epitope Diversity: An Evolving Area of Glycomics Research and Biomarker Discovery.Lectin switching during dengue virus infection A recombinant fungal lectin for labeling truncated glycans on human cancer cells Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines Role of endothelial N-glycan mannose residues in monocyte recruitment during atherogenesis.Carbohydrate chemistry in drug discovery.Cell surface protein glycosylation in cancer.The role of glycans in the development and progression of prostate cancer.Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells.The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells.Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.

P2860

Q33586407-D9CE4125-C799-4EE1-839E-411110DBBE23 Q33605256-64B4EA6B-F291-4B56-89F4-CFB380277DE5 Q33732475-2A317F98-A038-4BF7-8AC8-906753F4B650 Q34069601-46136D77-7635-4D94-8795-90605758E91D Q34157637-C04E106E-A5F0-413B-95D9-F91DD8A88418 Q34280520-6FA6107D-7381-48DF-8381-3AA09779C31A Q34449556-79539089-2F2A-4465-9DE6-EE40EEA0053F Q35000894-EF5FE823-B514-4F5C-B5BB-EEE8B9917CAC Q35652684-5657010E-B0A7-4AC3-8D7C-9C92F1003D2F Q36200540-EEDBC91A-07A7-4CE5-A8C1-98F0622A807F Q37317858-BE18AE30-29B5-42D7-9DD1-80FBBCE1B355 Q37853437-029D4600-14D6-481D-AA98-9615A0A879CB Q38171440-8F88D589-5FD4-4B05-BBC3-2A6609369002 Q38811520-8BE878BE-CFF9-46AC-849C-4FEE62DD6FF7 Q39608719-C2384D0B-6673-48C5-8DB3-2336BA694F1C Q42085701-B0F9C28E-811F-4393-94D6-4B92E79935E5 Q48787612-89AF3070-1B31-4A56-959A-88B8373A83AD Q53031449-8E8BEA6A-3072-471A-B55D-964370B2E593

P2860

Enhanced immune recognition of cryptic glycan markers in human tumors.

http://www.wikidata.org/entity/Q37133417

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Enhanced immune recognition of cryptic glycan markers in human tumors.

@en

Enhanced immune recognition of cryptic glycan markers in human tumors.

@nl

type

label

Enhanced immune recognition of cryptic glycan markers in human tumors.

@en

Enhanced immune recognition of cryptic glycan markers in human tumors.

@nl

prefLabel

Enhanced immune recognition of cryptic glycan markers in human tumors.

@en

Enhanced immune recognition of cryptic glycan markers in human tumors.

@nl

P1433

Q37133417-47CAF319-373B-476B-A2D5-F89D061AB903

P1476

Q37133417-B71DF6DB-DCDC-416D-B1CE-FE2046185510

P2093

Q37133417-3373ED10-77C4-4B46-8B69-E05DED59D7F9

Q37133417-4C530B0B-CED1-430E-AD49-6045A58ED0AF

Q37133417-774D0C68-98FA-42C7-9F41-9A6C41EE7EFB

Q37133417-79C05A98-A8EE-41E8-A8F5-4B0AB271FBE9

Q37133417-7A97B9F2-9059-4631-BF3E-0EABEABA6463

Q37133417-E19E55BA-1B34-41BE-BB63-FF0B61A00AD9

P2860

Q37133417-1169259C-B8A0-406A-8218-2CBBEE898FDB

Q37133417-12848688-53D5-4597-A376-845437ACEEB0

Q37133417-19AA8AD5-1449-436E-A1E8-D95E317BA94D

Q37133417-1BA60958-BD93-4BA5-998A-25864F047F80

Q37133417-1CBA9640-0ADD-4648-93AD-62BEACADB9AA

Q37133417-213E56EC-702D-4BAD-A657-97D892AE9BAA

Q37133417-2B9039D4-5CA2-4C83-A33C-84B3F38EA4F4

Q37133417-3DAE484B-5BBD-4363-8032-A7BEE293442C

Q37133417-3EF2A399-B460-4352-813A-8A0B010C8A78

Q37133417-3F7BCFD0-FE10-457F-BE17-15A1693B6F72

P304

Q37133417-42EF15EA-982C-417E-AA3F-4952EA8A8FD3

P31

Q37133417-A7C422EA-3381-44E0-AEC7-5EB9E80A7735

P356

Q37133417-25AA598F-1035-4515-ADB0-224C2F828AD9

P407

Q37133417-54BEB8D4-6559-4700-A2B9-3E2727D04CE1

P433

Q37133417-F0E1309A-37ED-44C3-A066-9125C3CA70AA

P478

Q37133417-8633278A-A0AA-4475-9E4C-22F16FDAFA9A

P50

Q37133417-DB0C834F-087A-4E45-9982-937EDF81EFBC

P577

Q37133417-DD6C1AD0-141D-4409-9C42-1A25DE582E74

P5875

Q37133417-AF418A0A-4DE7-418A-9D36-B30DF9B8D4AE

P698

Q37133417-0F957E13-F9CB-497D-9F2E-0FC8324B80EB

P932

Q37133417-C0BAF6D9-1412-4175-B321-EC18592A5A1F

P356

0008-5472.CAN-08-3589

P1433

Cancer Research

P1476

Enhanced immune recognition of cryptic glycan markers in human tumors.

@en

P2093

A Katharina Simon

http://www.w3.org/2001/XMLSchema#string

Denong Wang

http://www.w3.org/2001/XMLSchema#string

Lai-Xi Wang

http://www.w3.org/2001/XMLSchema#string

Lawrence Steinman

http://www.w3.org/2001/XMLSchema#string

Paul F-T Chen

http://www.w3.org/2001/XMLSchema#string

Thomas E Newsom-Davis

http://www.w3.org/2001/XMLSchema#string

P2860

Recognition of tumor glycans by antigen-presenting cells

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors.

Glycans in cancer and inflammation--potential for therapeutics and diagnostics.

Carbohydrate vaccines as immunotherapy for cancer.

Coupling and uncoupling of tumor immunity and autoimmunity.

Isolation and characterization of a second lectin (SNA-II) present in elderberry (Sambucus nigra L.) bark.

Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.

Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.

P304

2018-2025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3589

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Gavin R Screaton

P577

2009-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24021516

http://www.w3.org/2001/XMLSchema#string

P698

19223535

http://www.w3.org/2001/XMLSchema#string

P932

2657676

http://www.w3.org/2001/XMLSchema#string